About MIRA

Advancing a Focused Pipeline of Oral Medicines

MIRA Pharmaceuticals is a clinical-stage biotechnology company advancing novel oral therapies across pain and metabolic disease.

Our Story

Rethinking How Established Biology Becomes Medicine

MIRA was built around a straightforward idea: established biological mechanisms can hold therapeutic potential even when existing medicines have limitations. We design differentiated molecules intended to build on that biology while addressing limitations of earlier approaches.

The Problem​

The Biology Was Never the Problem

What held these mechanisms back wasn’t the biology. It was everything that came attached to it.

What held these mechanisms back wasn’t the biology. It was everything that came attached to it.

Leadership & Governance

The People Guiding MIRA Forward

Strategic architect of MIRA's pipeline. Drives capital markets and development strategy.

Erez Aminov

Chairman & Chief Executive Officer
More than 40 years in drug discovery. Former Head of Pharmacology at Sanofi/Synthelabo. Architect of the Ketamir-2 program and MIRA's pipeline.

Itzchak Angel, Ph.D

Chief Scientific Advisor
More than 30 years in drug development, supporting clinical translation and regulatory strategy, with decades of CMC expertise.

Alex Weisman, Ph.D.

Scientific Advisor
More than 20 years of SEC reporting and accounting experience. Leads financial reporting, compliance, and accounting.

Andriy Mushak

Chief Financial Officer
Strategic architect of MIRA's pipeline. Drives capital markets and development strategy.

Erez Aminov

Chairman & Chief Executive Officer
Dr. Matthew Del Giudice has practiced as a radiologist since 2014 and is an emergency radiologist at the Cleveland Clinic.

Matthew Del Giudice, MD

Director
Ned MacPherson serves as Chief Growth Officer for Power Digital, an industry-leading digital marketing agency.

Ned MacPherson

Director
Matthew Pratt Whalen is a Certified Public Accountant with more than two decades of experience in public accounting and corporate finance.

Matthew Pratt Whalen, CPA

Director
Dr. Denil N. Shekhat has practiced as a radiologist since 2014 and currently practices at DNS Teleradiology in Wellington, Florida.

Denil N. Shekhat, MD

Director

Connect With MIRA

Interested in Learning More About MIRA?

Connect with us to learn more about our programs, science, and corporate development.